Last week the scientific world was abuzz with the news that adult stem cells could be used to regenerate tissues and cure diseases. This week, the political world is abuzz with the news of President Bush’s veto of Congressional legislation and his own alternative Executive Order for Expanding Approved Stem Cell Lines in Ethically Responsible Ways. While the Usual Suspects are busy denouncing Bush for being anti-science, the media debate completely obscures the economic interests at stake. Big bio-tech companies stand to make money from government subsidy of embryonic stem cell research. By contrast, the use of stem cells from non-destructive sources have already produced cures, and will ultimately be cheaper to the health care consumer. (more…)